Video

Transportation to Cancer Treatments is An Issue for Many Patients

Author(s):

As transportation to treatments is one of the many important aspects patients with cancer must consider after receiving a diagnosis, there is room for improvement in terms of accessibility and affordability, says an expert from the Patient Access Network Foundation.

Transportation is a frequently overlooked, yet nonetheless important aspect of a patient’s cancer journey. Many patients have to work out the logistics on how they’re getting to and from treatment, which can become a large concern if they can’t afford or access transportation, says Ayesha Azam, Vice President of the Patient Access Network (PAN) Foundation.

In an interview with CURE®, Azam discussed the PAN Foundation’s goal of increasing accessibility to affordable transportation for patients.

“Part of our efforts are to draw attention to so many of the non-emergency medical transportation carriers that are across the U.S. that can provide people who maybe do have accessibility concerns, or maybe who don't have a car available to them, access to a vehicle that can take them safely to where they need to go,” Azam said.

Transcription:

It's such a pivotal role, and part of it has to do with the security and reliability of making sure that you can get your treatment and not have to worry about who's taking you to treatment.

We did a survey almost two years ago now, about all patients who are receiving copay assistance, many of which have cancelled. What we found from speaking to them is that most folks are relying on other people to be able to get to their doctor's office and pharmacies. And not only that, but the way that they’re traveling to the appointments may vary at each appointment. So, one time they might be relying on a friend or one time might be relying on a family member. And so, what we really found is that not only is there as big of a concern on the affordability end, but there was an equal level of concern on the accessibility end.

And so, part of our efforts are to draw to attention, so many of the non-emergency medical transportation carriers that are across the US that can provide people who maybe do have accessibility concerns, or maybe who don't have a car available to them, access to a vehicle that can take them safely to where they need to go.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Related Content